AA
SBC

AQR Arbitrage’s SBC Medical Group SBC Stock Holding History

AQR Arbitrage’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-366,025
Closed -$3.81M – 932
2023
Q1 		$3.81M Sell
366,025
-8,975
-2% -$92.7K 0.12% 228
2022
Q4 		$3.84M Buy
+375,000
New +$3.79M 0.1% 284

Other funds holding SBC

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $60.8M AUM 17.47% 1-Year Est. Return

AQR Arbitrage's SBC Position: Q2 2023 in Review

AQR Arbitrage sold out of SBC Medical Group (SBC) in Q2 2023, closing a stake of 366,025 shares — an estimated $3.81M sold.

AQR Arbitrage first reported a position in SBC in Q4 2022 and held it in 2 quarters. The position peaked at $3.84M in Q4 2022. 13 funds tracked by Wall St. Rank hold SBC as of Q2 2023.

  • AQR Arbitrage reported no remaining SBC Medical Group position as of Q2 2023 after selling out during the quarter.
  • AQR Arbitrage sold 366,025 SBC Medical Group shares in Q2 2023, an estimated $3.81M.
  • AQR Arbitrage first reported a position in SBC Medical Group in Q4 2022 and held it in 2 quarters.
  • AQR Arbitrage's SBC Medical Group position peaked at $3.84M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2023.

Based on AQR Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.